Population-level effectiveness of alternative approaches to preventing mental disorders in adolescents and young adults.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
15 11 2023
15 11 2023
Historique:
received:
22
01
2023
accepted:
12
11
2023
medline:
17
11
2023
pubmed:
16
11
2023
entrez:
15
11
2023
Statut:
epublish
Résumé
Preventive interventions that are effective in reducing the incidence of mental disorders in adolescence and early adulthood may impact substantially on lifetime economic, educational, and health outcomes; however, relatively few studies have examined the capacity of alternative approaches to preventing youth mental disorders (specifically, universal, selective, and indicated prevention) to reduce disorder incidence at a population level. Using a dynamic model of the onset of non-specific, relatively mild symptoms and progression to more severe disease, we show that: (1) indicated preventive interventions, targeting adolescents and young adults experiencing subthreshold symptoms, may often be more effective in reducing mental disorder prevalence than universal interventions delivered to the general population (contrary to the widely accepted view that a 'high risk' prevention strategy, focussing on those individuals with the greatest risk of developing a disorder, will generally be less effective than a whole-population strategy); and (2) the ability of selective preventive interventions (targeting vulnerable, asymptomatic youth) to alter the prevalence of mental disorders is severely restricted by an inverse relationship between the prevalence of significant risk factors for mental illness and the relative risk of developing symptoms.
Identifiants
pubmed: 37968445
doi: 10.1038/s41598-023-47322-2
pii: 10.1038/s41598-023-47322-2
pmc: PMC10652005
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
19982Informations de copyright
© 2023. The Author(s).
Références
JAMA. 2004 Jun 2;291(21):2581-90
pubmed: 15173149
Am J Public Health. 2006 Mar;96(3):452-8
pubmed: 16449591
Lancet. 2016 Jun 11;387(10036):2423-78
pubmed: 27174304
Am J Psychiatry. 2008 Oct;165(10):1272-80
pubmed: 18765483
JAMA Psychiatry. 2021 Mar 1;78(3):302-310
pubmed: 33295952
World Psychiatry. 2021 Jun;20(2):200-221
pubmed: 34002494
Mol Psychiatry. 2022 Jan;27(1):281-295
pubmed: 34079068
J Consult Clin Psychol. 2009 Jun;77(3):486-503
pubmed: 19485590
BMJ. 2012 Jul 31;345:e4933
pubmed: 22849956
Acta Psychiatr Scand. 2019 Oct;140(4):371-381
pubmed: 31254386
Lancet. 2014 Apr 19;383(9926):1404-11
pubmed: 24439298
Lancet Psychiatry. 2018 Apr;5(4):357-369
pubmed: 29580610
Br J Psychiatry. 2010 Aug;197(2):122-7
pubmed: 20679264
JAMA Psychiatry. 2017 Oct 1;74(10):1021-1029
pubmed: 28877316
Med J Aust. 2019 Nov;211 Suppl 9:S3-S46
pubmed: 31679171
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
Psychol Med. 2016 Jan;46(1):11-26
pubmed: 26315536